Form Type:  8-K
Filing Date:  9/2/2022 
CIK:  0001504167 
Address:  110 ALLEN ROAD, SUITE 401 
City, State, Zip:  BASKING RIDGE, New Jersey 07920 
Telephone:  914-205-3481 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
-0.02 (-0.85%)  
Trade Time: 
10:34 AM EST  
Market Cap: 
Trade TMBR now with

© 2023  
Description of Business
Timber Pharmaceuticals, Inc. ("Timber", the "Company", "we", "us") is a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. Our investigational therapies have proven mechanisms-of-action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing and control) and safety profiles. We are initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis ("CI"), facial angiofibromas ("FAs") in tuberous sclerosis complex ("TSC"), and sclerotic skin diseases. Our lead mid to late-stage programs are TMB-001 and TMB-002. TMB-003 is our earliest stage program.
Register and access this filing in:     
  FORM 8-K
      Item 2.01 Results of Operations and Financial Condition.

EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Markets Group Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.